Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Roche’s Ocrevus Approved by China’s NMPA for Multiple Sclerosis Treatment
March 31, 2025
Company
Medical Device
Shanghai Bio-heart Launches SAKURA-SCB Study for Drug-Coated Balloon in Japan
March 31, 2025
Company
Drug
AstraZeneca’s Imfinzi Approved by FDA for Bladder Cancer Treatment
March 31, 2025
Company
MicroPort Endovascular Reports 1.61% Revenue Growth in 2024 with Strong Profit Increase
March 31, 2025
Company
Luye Pharma Group Reports 2024 Revenue Dip Despite Growth in Product Sales
March 31, 2025
Company
Hengrui Pharmaceuticals Reports 22.63% Revenue Growth in 2024 with Strong Innovative Drug Sales
March 31, 2025
Company
Drug
Sanofi’s Qfitlia Approved by FDA for Hemophilia A and B Prophylaxis
March 31, 2025
Company
Drug
Brii Biosciences Presents Elebsiran Phase II Data at APASL 2025 Meeting
March 31, 2025
Company
Akeso Biopharma Reports 53% Revenue Decline in 2024 Despite Growth in Product Sales
March 31, 2025
Company
Drug
IASO Biotherapeutics’ Fucaso Approved in Macao for Relapsed Multiple Myeloma
March 31, 2025
Company
Drug
Eli Lilly Launches Kisunla in China for Early Alzheimer’s Treatment
March 31, 2025
Company
Drug
Laekna Submits Revised Protocol for LAE102 Obesity Trial with Eli Lilly
March 31, 2025
1
2
3
4
…
31
32
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
